Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Imine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN118619916A reveals additive-free synthesis. Offers cost reduction and supply chain reliability for high-purity pharmaceutical intermediates.
Patent CN101113138B details a safe cyanation method using ferrocene imine cyclopalladium complexes. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel synthesis of Tetrabenazine API intermediate using imine salts. Reduces cost and improves regioselectivity compared to conventional methods.
Patent CN108164555B reveals a high-efficiency rare earth catalyst for boronic ester synthesis, offering mild conditions and significant cost reduction in fine chemical manufacturing.
Novel imidazolium-functionalized ferrocene ligands enable high-yield asymmetric allylic substitution with recyclable catalyst properties for pharmaceutical intermediates.
Patent CN114716359B details a novel silver-catalyzed route for hydroindole imines, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN106986900B details a novel sodium methoxide catalyzed route for N-alkylglucosimine. This method ensures high purity and scalability for surfactant intermediates.
Patent CN102304007B reveals high-ee asymmetric hydrogenation using chiral Ru catalysts enabling cost reduction in pharmaceutical intermediate manufacturing with scalable processes.
Patent CN101486737A discloses a novel quaternary ammonium ferrocene ligand enabling high-yield asymmetric allylic substitution with simplified catalyst recovery for cost-effective manufacturing.
Patent CN110305025B details a green photocatalytic method for benzylamine synthesis using Eosin Y and water, offering significant cost and safety advantages for pharmaceutical intermediates.
Novel metal-free synthesis method for N-trifluoromethylthio-isochromene-1-imine compounds ensures high yield and cost efficiency for pharmaceutical intermediate supply chains globally.
Novel metal-free route for azaspiro compounds offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally ensuring high purity standards.
Patent CN115353482B reveals metal-free synthesis for high-purity azaspiro compounds. Enables cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Novel metal-free synthesis of trifluoromethyl 1,2,4-triazines via [3+3] cycloaddition. Cost-effective, scalable route for pharma intermediates.
Patent CN113105402A reveals a novel iodine-promoted synthesis for trifluoromethyl-triazoles, offering significant cost reduction in API manufacturing and scalable production capabilities.
Patent CN113105402A reveals a metal-free iodine-catalyzed route for 3,4,5-trisubstituted 1,2,4-triazoles, offering significant cost reduction in API manufacturing and scalable production.
Patent CN106938976B enables transition-metal-free imine synthesis. Achieve high-purity pharmaceutical intermediates with reduced environmental costs and scalable production.
Patent CN103214394B enables high-yield room temperature synthesis. Reduces cost and lead time for pharmaceutical intermediates manufacturing with scalable processes.
Novel Pd-catalyzed one-pot synthesis of benzo[c,d]indole imines. Reduces steps, eliminates toxic mercury, ensures high purity for drug discovery.
Novel metal-free synthesis of trifluoromethyl 1,2,4-triazines via [3+3] cycloaddition. Cost-effective, scalable route for pharma intermediates.